These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Oncolytic viruses: a novel form of immunotherapy. Prestwich RJ; Harrington KJ; Pandha HS; Vile RG; Melcher AA; Errington F Expert Rev Anticancer Ther; 2008 Oct; 8(10):1581-8. PubMed ID: 18925850 [TBL] [Abstract][Full Text] [Related]
28. Active immunotherapy: oncolytic virus therapy using HSV-1. Todo T Adv Exp Med Biol; 2012; 746():178-86. PubMed ID: 22639168 [TBL] [Abstract][Full Text] [Related]
29. Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment Conversion towards Immunogenicity. Angelova AL; Barf M; Geletneky K; Unterberg A; Rommelaere J Viruses; 2017 Dec; 9(12):. PubMed ID: 29244745 [TBL] [Abstract][Full Text] [Related]
30. Current Advances in Immunotherapy for Glioblastoma. Mende AL; Schulte JD; Okada H; Clarke JL Curr Oncol Rep; 2021 Jan; 23(2):21. PubMed ID: 33496872 [TBL] [Abstract][Full Text] [Related]
31. Oncolytic herpes simplex virus immunovirotherapy in combination with immune checkpoint blockade to treat glioblastoma. Saha D; Martuza RL; Rabkin SD Immunotherapy; 2018 Jul; 10(9):779-786. PubMed ID: 30008259 [TBL] [Abstract][Full Text] [Related]
32. Defining Effective Combinations of Immune Checkpoint Blockade and Oncolytic Virotherapy. Rojas JJ; Sampath P; Hou W; Thorne SH Clin Cancer Res; 2015 Dec; 21(24):5543-51. PubMed ID: 26187615 [TBL] [Abstract][Full Text] [Related]
33. Diplomatic immunity: turning a foe into an ally. Parato KA; Lichty BD; Bell JC Curr Opin Mol Ther; 2009 Feb; 11(1):13-21. PubMed ID: 19169955 [TBL] [Abstract][Full Text] [Related]
34. Immunovirotherapy with measles virus strains in combination with anti-PD-1 antibody blockade enhances antitumor activity in glioblastoma treatment. Hardcastle J; Mills L; Malo CS; Jin F; Kurokawa C; Geekiyanage H; Schroeder M; Sarkaria J; Johnson AJ; Galanis E Neuro Oncol; 2017 Apr; 19(4):493-502. PubMed ID: 27663389 [TBL] [Abstract][Full Text] [Related]
35. Dichloroacetate blocks aerobic glycolytic adaptation to attenuated measles virus and promotes viral replication leading to enhanced oncolysis in glioblastoma. Li C; Meng G; Su L; Chen A; Xia M; Xu C; Yu D; Jiang A; Wei J Oncotarget; 2015 Jan; 6(3):1544-55. PubMed ID: 25575816 [TBL] [Abstract][Full Text] [Related]
36. Molecular Pathways: Mechanism of Action for Talimogene Laherparepvec, a New Oncolytic Virus Immunotherapy. Kohlhapp FJ; Kaufman HL Clin Cancer Res; 2016 Mar; 22(5):1048-54. PubMed ID: 26719429 [TBL] [Abstract][Full Text] [Related]
37. Potent Antitumor T-Cell Memory Is Generated by Curative Viral Oncolytic Immunotherapy But Not Curative Chemotherapy. Gao Y; Bergman I Anticancer Res; 2018 Dec; 38(12):6621-6629. PubMed ID: 30504370 [TBL] [Abstract][Full Text] [Related]